- Home
- FARO vs CVAC Comparison
FARO vs CVAC Comparison
Compare FARO & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FARO
- CVAC
- Stock Information
- Founded
- FARO 1981
- CVAC 2000
- Country
- FARO United States
- CVAC Germany
- Employees
- FARO N/A
- CVAC N/A
- Industry
- FARO Industrial Machinery/Components
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- FARO Industrials
- CVAC Health Care
- Exchange
- FARO Nasdaq
- CVAC Nasdaq
- Market Cap
- FARO 819.6M
- CVAC 764.4M
- IPO Year
- FARO 1997
- CVAC 2020
- Fundamental
- Price
- FARO $43.72
- CVAC $5.44
- Analyst Decision
- FARO Buy
- CVAC Buy
- Analyst Count
- FARO 2
- CVAC 3
- Target Price
- FARO $35.50
- CVAC $9.00
- AVG Volume (30 Days)
- FARO 749.2K
- CVAC 2.1M
- Earning Date
- FARO 08-07-2025
- CVAC 08-14-2025
- Dividend Yield
- FARO N/A
- CVAC N/A
- EPS Growth
- FARO N/A
- CVAC N/A
- EPS
- FARO N/A
- CVAC 0.87
- Revenue
- FARO $341,046,000.00
- CVAC $566,039,775.00
- Revenue This Year
- FARO $3.49
- CVAC N/A
- Revenue Next Year
- FARO $5.72
- CVAC $24.04
- P/E Ratio
- FARO N/A
- CVAC $6.34
- Revenue Growth
- FARO N/A
- CVAC 787.60
- 52 Week Low
- FARO $13.52
- CVAC $2.37
- 52 Week High
- FARO $43.90
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- FARO 80.93
- CVAC 68.03
- Support Level
- FARO $42.33
- CVAC $4.07
- Resistance Level
- FARO $43.90
- CVAC $5.58
- Average True Range (ATR)
- FARO 0.26
- CVAC 0.20
- MACD
- FARO -0.27
- CVAC 0.07
- Stochastic Oscillator
- FARO 88.96
- CVAC 83.08
About FARO FARO Technologies Inc.
Faro Technologies Inc is a technology company. It designs, develops, manufactures, markets and supports software-driven, three-dimensional (3-D) measurement, imaging, and realization solutions for the 3D metrology, architecture, engineering and construction (AEC), Operations and Maintenance (O&M) and public safety analytics markets. The company enables its customers to capture, measure, manipulate, interact with and share 3D and 2D data from the physical world in a virtual environment and then translate the information back into the physical domain. FARO suite of 3D products and software solutions are used for the inspection of components and assemblies, rapid prototyping, reverse engineering, documenting large volumes or structures in 3D, surveying, and construction.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.